Aaron Smith
AstraZeneca (United Kingdom)(GB)The Francis Crick Institute(GB)University of Warwick(GB)AstraZeneca (Singapore)(SG)Profectus Biosciences (United States)(US)Cogent Biosciences (United States)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Advanced Battery Technologies Research, Advancements in Battery Materials, Phytochemicals and Medicinal Plants, Toxin Mechanisms and Immunotoxins
Most-Cited Works
- → Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists(2016)364 cited
- → Precision Measurements of the Coulombic Efficiency of Lithium-Ion Batteries and of Electrode Materials for Lithium-Ion Batteries(2009)362 cited
- → AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity(2019)327 cited
- → The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models(2018)302 cited
- → Interpreting High Precision Coulometry Results on Li-ion Cells(2011)297 cited
- → A High Precision Coulometry Study of the SEI Growth in Li/Graphite Cells(2011)282 cited